title: Dendritic cell vaccine and cancer treatment: new patents.
abstract: Dendritic cell (DC) immunotherapy has been used to treat various types of tumors. Although it is already in use in clinical practice, the mechanisms through which it acts need clarification. In addition, the processes used to obtain DCs need to be improved so that more effective treatments can be offered. In this article, we present an update on the application of DC immunotherapy and the patents involved in the process.
authors.forename: André A R
authors.initials: AA
authors.lastname: Aleixo
authors.forename: Márcia A
authors.initials: MA
authors.lastname: Michelin
authors.affiliation: Oncology Research Institute (IPON), Discipline of Gynecology and Obstetrics, (UFTM), Avenida Getulio Guarita, sn, Uberaba (MG), CEP 38025-440, Bairro Abadia, Brazil. eddiemurta@mednet.com.br.
authors.forename: Eddie F C
authors.initials: EF
authors.lastname: Murta
mesh_terms: D019496:Cancer Vaccines / Q000276:immunology*; D003713:Dendritic Cells / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D010330:Patents as Topic
chemical_list: D019496:Cancer Vaccines